Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Dose Size and Dosing Frequency: Determination Methods

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Pharmaceutical Year That Was, 2025.

Pharmaceutical medicine·2025

Same author

Author's Reply to Pongpirul: "The Pharmaceutical Year that was, 2024".

Pharmaceutical medicine·2024

Same author

The Pharmaceutical Year that was, 2024.

Pharmaceutical medicine·2024

Same author

The Pharmaceutical Year That Was, 2023.

Pharmaceutical medicine·2023

Same author

Where is European Regulation 536/2014 Taking Us?

Pharmaceutical medicine·2023

Same author

The Pharmaceutical Year that was, 2021.

Pharmaceutical medicine·2021

Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026

Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026

Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026

Same journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026

Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026

Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Disease modification in migraine: study design and sample size implications.

Anthony W Fox¹

¹Skaggs SPPS, University of California, San Diego, CA, USA.

|September 27, 2008

Summary

This summary is machine-generated.

This study presents a clinical trial design to detect disease-modifying effects (DME) of anti-migraine drugs. The model indicates that typical prophylactic agents may not require impractically large patient numbers for DME detection.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Related Experiment Videos

Last Updated: Jun 30, 2026

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Area of Science:

Clinical trial design
Pharmacology
Neurology

Background:

Migraine treatment research often focuses on symptomatic relief.
Detecting disease-modifying effects (DME) is crucial for developing more effective long-term therapies.
Existing trial designs may not be optimized for detecting subtle DME in migraine.

Purpose of the Study:

To propose a clinical trial design capable of detecting the disease-modifying effects (DME) of anti-migraine medications.
To analyze how variability in active and placebo response rates impacts required study size for DME detection.

Main Methods:

Developed a model using standard power calculations and typical response rates for migraine prophylactic drugs.
Analyzed the interplay between active response rate (ARR), placebo response rate (PRR), and sample size as a 3D problem.
Incorporated allowances for patient loss to follow-up.

Main Results:

The proposed design requires approximately four times the number of patients per group compared to standard trials when positive and negative controls are used.
For an agent with 50% ARR and 25% PRR, around 260-270 patients per group may be needed.
Sample size increases quasi-exponentially with rising placebo response rates and falling active response rates.

Conclusions:

A straightforward modeling technique can assess study design variations for DME detection.
Investigating DME for typical prophylactic migraine agents may be feasible with manageable patient numbers.
These models aid in both clinical trial design and assessing the feasibility of DME detection programs.